Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action

European Journal of Pharmacology

Volumn 345, Issue 3, 1998, Pages 233-245

  Beirith, Alessandra ^a   Santos, Adair R S ^a   Rodrigues, Ana L S ^a   Creczynski Pasa, Tânia B ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

(Mouse); Antinociception; Capsaicin test; Dipyrone; Formalin test; Glutamate binding; Glutamate test; Hot plate test; Neurogenic pain; Nitric oxide (NO); Pain; Tail flick test

Indexed keywords

ARGININE; CAPSAICIN; DIPYRONE; FENCLONINE METHYL ESTER; FORMALDEHYDE; GLIBENCLAMIDE; GLUTAMIC ACID; NALOXONE; PERTUSSIS TOXIN; PHACLOFEN; POTASSIUM CHANNEL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; DRUG MECHANISM; HOT PLATE TEST; HYPERALGESIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LATENT PERIOD; LICKING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANIMALS; CAPSAICIN; DIPYRONE; ENZYME INHIBITORS; FORMALDEHYDE; GLUTAMIC ACID; HYPERALGESIA; MALE; MICE; MUSCULOSKELETAL EQUILIBRIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PAIN; PAIN MEASUREMENT; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REACTION TIME; SPINAL CORD;

EID: 0032568302     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00026-0     Document Type: Article

References (55)

1. Aanonsen, L.M., Wilcox, G.L., 1987. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J. Pharmacol. Exp. Ther. 243, 9-19.
2. Abbate, R., Gori, A.M., Pinto, S., Attanasio, M., Paniccia, R., Coppo, M., Castellani, S., Giusti, B., Boddi, M., Neri, S.G.G., 1990. Cycloxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. Prostaglandins Leukotrienes Essent. Fatty Acids 41, 89-93.
3. Bredt, D.S., Snyder, S.H., 1990. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682-685.
4. Carlsson, K.H., Jurna, I., 1987. The role of descending inhibition in the antinociceptive effects of the pyrazolone derivatives, metamizole (dipyrone) and aminophenazone ('Pyramidon'). Naunyn-Schmiedebergs's Arch. Pharmacol. 335, 149-154.
5. Carlsson, K.H., Helmreich, J., Jurna, I., 1986. Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizole (dipyrone). Pain 27, 373-390.
6. Coderre, T.J., Melzack, R., 1992. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J. Neurosci. 12, 3665-3670.
7. Coderre, T.J., Van Empel, I., 1994. The utility of excitatory amino acid (EAA) antagonists as analgesic agents: II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric glycine and polyamine receptor sites. Pain 59, 353-359.
8. Corrêa, C.R., Calixto, J.B., 1993. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol. 110, 193-198.
9. Corrêa, C.R., Kyle, D.J., Chakravarty, S., Calixto, J.B., 1996. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br. J. Pharmacol. 117, 552-558.
10. D'Amour, F.E., Smith, D.L., 1941. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72, 74-79.
11. Dickenson, A.M., 1995. Central acute pain mechanisms. Ann. Med. 27, 223-227.
12. Dray, A., 1995. Inflammatory mediators of pain. Br. J. Anaesth. 75, 125-131.
13. Dougherty, P.M., Willis, W.D., 1991. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain 47, 85-93.
14. Duarte, I.D., Santos, I.R., Lorenzetti, B.B., Ferreira, S.H., 1992. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 217, 225-227.
15. Eddy, N.B., Leimbach, D., 1953. Synthetic analgesics: II. Dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107, 385-393.
16. Eisenberg, E., Vos, B.P., Strassman, A.M., 1993. The NMDA antagonist memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain 54, 301-307.
17. Engelhardt, G., Homma, D., Schlegel, K., Utzmann, R., Schnitzler, C., 1995. Antiinflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm. Res. 44, 423-433.
18. Ferreira, S.H., 1993. The role of interleukinin and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs 46, 1-9.
19. Ferreira, S.H., Lorenzetti, B.B., 1994. Glutamate spinal retrograde sensiti-zation of primary sensory neurons associated with nociception. Neuropharmacology 33, 1479-1485.
20. Ferreira, S.H., Lorenzetti, B.B., Correa, F.M.A., 1978. Central and peripheral antialgic action of aspirin-like drugs. Eur. J. Pharmacol. 53, 39-48.
21. Gelgor, L., Cartmell, S., Mitchell, D., 1992. Intracerebroventricular micro-injections of non-steroidal anti-inflammatory drug abolish reperfusion hyperalgesia in the rat's tail. Pain 50, 323-329.
22. Granados, S.V., Flores, M.F.J., Castaneda, H.G., Lopez, M.F.J., 1995. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac. Eur. J. Pharmacol. 277, 281-284.
23. Haley, J.E., Sullivan, A.F., Dickenson, A.M., 1990. Evidence for spinal Af-methyl-D-aspartate receptor involvement prolonged chemical nociception in the rat. Brain Res. 518, 218-226.
24. Hernandez, A., Soto-Moyano, R., Mestre, C., Eschalier, A., Pelissier, T., Paeile, C., Contreras, E., 1995. Intrathecal pertussis toxin but not cyclic AMP blocks kappa opioid-induced antinociception in rat. Int. J. Neurosci. 81, 193-197.
25. Hylden, J.K.L., Wilcox, G.L., 1980. Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67, 313-316.
26. Knowles, R.G., Palacios, M., Palmer, R.M.J., Moncada, S., 1990. Kinetic characteristics of nitric synthase from rat brain. Biochem. J. 269, 207-210.
27. Laursen, S.E., Belknap, J.K., 1986. Intracerebroventricular injections in mice: Some methodological refirements. J. Pharmacol. Methods 16, 355-357.
28. Liu, H., Mantyh, P.W., Basbaum, A.I., 1997. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386, 721-724.
29. López-Muñoz, F.J., Villalón, C.M., Terrón, J.A., Salazar, L.A., 1994. Analgesic interactions produced by dipyrone and either morphine or D-propoxyphene in the pain-induced functional impairment model in rat. Drug Dev. Res. 32, 50-57.
30. Lorenzetti, B.B., Ferreira, S.H., 1985. Mode of analgesic action of dipyrone: direct antagonism of inflammatory hyperalgesia. Eur. J. Pharmacol. 114, 375-381.
31. Lorenzetti, B.B., Ferreira, S.H., 1996. Activation of the arginine-nitric oxide pathway in primary sensory neurones contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm. Res. 45, 308-311.
32. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
33. B antagonist, prevents antinociception and muscle-relaxant effect by baclofen. Br. J. Pharmacol. 103, 1303-1308.
34. Malmberg, A.B., Yaksh, T.L., 1992. Antinociceptive actions of nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263, 136-146.
35. Mao, J., Price, D.D., Hayes, R.L., Lu, J., Mayer, D.J., 1992. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 598, 271-278.
36. Meller, S.T., Gebhart, G.F., 1993. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52, 127-136.
37. Raffa, R.B., Martinez, R.P., 1995. The 'glibenclamide-shift' of centrally-acting antinociceptive agents in mice. Brain Res. 677, 277-282.
38. Rosland, J.H., Hunskaar, S., Hole, K., 1990. Diazepam attenuates morphine antinociception test-dependently in mice. Pharmacol. Toxicol. 66, 382-386.
39. Rusin, K.I., Bleakman, D., Chard, P.S., Randic, M., Miller, R.J., 1993. Tachykinins potentiate N-methyl-D-aspartate responses in acutely isolated neurons from the dorsal horn. J. Neurochem. 60, 952-960.
40. Sánchez-Blázquez, P., Garzón, J., 1991. Cholera toxin and pertussis toxin an opioid- and -α2-mediated supraspinal analgesia in mice. Life Sci. 48, 1721-1727.
41. Santos, A.R.S., Calixto, J.B., 1997. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides 31, 381-389.
42. Santos, A.R.S., Cechinel Filho, V., Yunes, R.A., Calixto, J.B., 1995. Analysis of the mechanisms underlying the antinociceptive effect of the extracts of plants from the genus Phyllanthus. Gen. Pharmacol. 26, 1499-1506.
43. Shewade, D.G., Ramaswamy, S., 1995. Prolactin-induced analgesia is dependent on ATP-sensitive potassium channels. Clin. Exp. Pharmacol. Physiol. 22, 635-636.
44. Shibata, M., Ohkubo, T., Takahashi, H., Inoki, R., 1989. Modified formalin test: characteristic biphasic pain response. Pain 38, 347-352.
45. Shimada, S.G., Otterness, I.G., Stitt, J.T., 1994. A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions 41, 188-192.
46. Souza, D.O., Ramírez, G., 1991. Effects of guanine nucleotides on kainic acid binding and on adenylate cyclase in chick optic tectum and cerebellum. J. Mol. Neurosci. 3, 39-45.
47. Taber, R.I., Lantranyi, A.V., 1981. Antagonism of the analgesic effect of opioid and non-opioid agents by p-chlorophenylalanine (PCPA). Eur. J. Pharmacol. 75, 215-222.
48. Tonussi, C.R., Ferreira, S.H., 1994. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur. J. Pharmacol. 251, 173-179.
49. Tracey, D.J., Walker, J.S., 1995. Pain due to nerve damage: Are inflammatory mediators involved?. Inflamm. Res. 44, 407-411.
50. Vaz, Z.R., Cechinel Filho, V., Yunes, R.A., Calixto, J.B., 1996. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel Xanthoxyline derivative on chemical and thermal models of nociception in mice. J. Phamacol. Exp. Ther. 278, 304-312.
51. Von Voigtlander, P.F., Lewis, R.A., Neff, G.L., 1984. Kappa-opioid analgesia is dependent on serotonergic mechanisms. J. Pharmacol. Exp. Ther. 231, 270-274.
52. 3 pituitary cells. Biochem. J. 285, 201-205.
53. Yamamoto, T., Yaksh, T.L., 1992a. Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK-801, a NMDA antagonist, on the formalin test in the rat. Anesthesiology 77, 757-763.
54. Yamamoto, T., Yaksh, T.L., 1992b. Spinal pharmacology of thermal hyperethesia induced by constriction injury of sciatic nerve: II. Excitatory amino acid antagonists. Pain 49, 121-128.
55. Zimmermann, M., 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.